Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Applied Dna Scns (NQ: APDN )

1.060 -0.020 (-1.85%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 33,190
Open 1.070
Bid (Size) 1.030 (20)
Ask (Size) 1.100 (1)
Prev. Close 1.080
Today's Range 1.020 - 1.111
52wk Range 0.6243 - 7.350
Shares Outstanding 12,908,520
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Applied DNA Submits Validation Package to New York State Department of Health for Approval of Pharmacogenomic (PGx) Assay
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Sciences's Return On Capital Employed Insights
 
Via Benzinga

Performance

YTD
-32.48%
-32.48%
1 Month
-33.33%
-33.33%
3 Month
-19.08%
-19.08%
6 Month
-21.48%
-21.48%
1 Year
-54.89%
-54.89%

More News

Read More
Applied DNA Announces New York State Award Valued at Up To $1.5 Million to Support Establishment of cGMP linearDNA™ Production Capacity on Long Island, New York
From Applied DNA Sciences, Inc.
Via Business Wire
Earnings Outlook For Applied DNA Sciences
Via Benzinga
Preview: Applied DNA Sciences's Earnings
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Applied DNA Reports First Quarter Fiscal 2023 Financial Results
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA to Report First Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, February 9, 2023
From Applied DNA Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Applied DNA Announces Publication of Peer-Reviewed Journal Article Validating Potential Use of linearDNA™ as a New Class of DNA-Based Vaccines
From Applied DNA Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Applied DNA Announces Fourth Quarter and Fiscal Year 2022 Financial Results
From Applied DNA Sciences, Inc.
Via Business Wire
Earnings Scheduled For December 14, 2022
Via Benzinga
Applied DNA to Report Fiscal 2022 Fourth Quarter and Year End Financial Results on December 14, 2022
From Applied DNA Sciences, Inc.
Via Business Wire
Earnings Scheduled For December 12, 2022
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Applied DNA to Establish North America’s First Enzymatic (Cell Free) Large-Scale cGMP DNA Manufacturing Capacity in Suffolk County, New York
From Applied DNA Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Laser Photonics Shares Surged By Around 19%; Here Are 70 Biggest Movers From Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Morgan Stanley Shares Are Trading Lower, Here Are 43 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why T2 Biosystems Shares Are Trading Lower By Over 28%, Here Are 41 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Norwegian Cruise Line Shares Climbed By Around 12%; Here Are 66 Biggest Movers From Yesterday
Via Benzinga
Why Leggett & Platt Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket
Via Benzinga
Why ForgeRock Shares Are Trading Higher By Over 49%, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.